BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28038452)

  • 1. Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer.
    Zhen S; Hua L; Liu YH; Sun XM; Jiang MM; Chen W; Zhao L; Li X
    Oncotarget; 2017 Feb; 8(6):9634-9646. PubMed ID: 28038452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout.
    Zhen S; Lu J; Chen W; Zhao L; Li X
    Hum Gene Ther; 2018 Dec; 29(12):1352-1363. PubMed ID: 30457360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
    Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
    Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion.
    Xue M; Li X; Li Z; Chen W
    Tumour Biol; 2014 Jul; 35(7):6901-12. PubMed ID: 24737584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome.
    Zhen S; Takahashi Y; Narita S; Yang YC; Li X
    Oncotarget; 2017 Feb; 8(6):9375-9387. PubMed ID: 28030843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.
    Xue M; Li X; Wu W; Zhang S; Wu S; Li Z; Chen W
    Oncol Rep; 2014 May; 31(5):1993-2000. PubMed ID: 24648007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.
    Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X
    Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.
    Gou L; Liu M; Xia J; Wan Q; Jiang Y; Sun S; Tang M; Zhou L; He T; Zhang Y
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells.
    Wang X; Gong Y; Jin B; Wu C; Yang J; Wang L; Zhang Z; Mao Z
    Oncol Rep; 2014 Sep; 32(3):1281-90. PubMed ID: 24993775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells.
    Wu W; Zhang S; Li X; Xue M; Cao S; Chen W
    PLoS One; 2013; 8(9):e73920. PubMed ID: 24069250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
    Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPβ promotes the viability of human bladder cancer cell by contributing to the transcription of bladder cancer specific lncRNA UCA1.
    Jin B; Gong Y; Li H; Jiao L; Xin D; Gong Y; He Z; Zhou L; Jin Y; Wang X; Zhang Z
    Biochem Biophys Res Commun; 2018 Nov; 506(3):674-679. PubMed ID: 30376994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
    Li J; Li Y; Meng F; Fu L; Kong C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
    Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay.
    Eissa S; Matboli M; Essawy NO; Shehta M; Kotb YM
    Biomarkers; 2015; 20(3):212-7. PubMed ID: 26161701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
    Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of long non-coding RNA UCA1 inhibits proliferation and invasion and induces apoptosis in human lung cancer cells.
    Jun T; Zheng FS; Ren KM; Zhang HY; Zhao JG; Zhao JZ
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7274-7281. PubMed ID: 30468471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.